Efficacy and safety of empagliflozin as add‐on to insulin in Japanese patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled trial

por Sone, Hirohito, Kaneko, Tatsuroh, Shiki, Kosuke, Tachibana, Yoshifumi, Pfarr, Egon, Lee, Jisoo, Tajima, Naoko
Publicado 2019

Empagliflozin Induces Transient Diuresis Without Changing Long-Term Overall Fluid Balance in Japanese Patients With Type 2 Diabetes

por Yasui, Atsutaka, Lee, Ganghyuck, Hirase, Tetsuaki, Kaneko, Tatsuroh, Kaspers, Stefan, von Eynatten, Maximilian, Okamura, Tomoo
Publicado 2018